ThePrint asks doctors about the science and risks of GLP-1 microdosing
Doctors weigh in on taking small doses of Ozempic-style drugs, covering what the evidence shows and the risks they see in the trend.
Recap by typeshit. Full story at ThePrint.
Doctors weigh in on taking small doses of Ozempic-style drugs, covering what the evidence shows and the risks they see in the trend.
Recap by typeshit. Full story at ThePrint.
Dr. Nadolsky, an obesity medicine doctor, gives his take on a recent GLP-1 warning in a short clip. Tap through to see which warning he means.
14:36
A short look at the less discussed side effects of the experimental weight loss shot retatrutide, which is still in trials and not approved.
2:12
A short explainer on the experimental injection people call Reta, covering why it went viral and what is known so far about its safety.
A nationwide recall now covers a GLP-1 injectable. The full story names the affected medication and explains why it was pulled.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
The non-binding vote went against the FDA's own scientists, who opposed every peptide. Six of the eight new panel members run clinics that offer peptides.
Loading…